hero banner

hero banner

Semintra Oral Solution for Cats 10 mg/ml, 35 ml Rx

Sorry, there is a back order on this item

I'm not a Robot.
reCAPTCHA
Invalid ReCaptcha.

You may also like

One-time purchase My Price $25.00
One-time purchase My Price $10.00
Semintra Oral Solution for Cats 10 mg/ml, 35 ml Description
SEMINTRA® (telmisartan oral solution) is the only FDA-approved treatment that helps control your cat’s hypertension. Prescribed by your veterinarian, SEMINTRA is an easy-to-give liquid medication that’s designed to provide safe and effective long-term control of high blood pressure in cats. A convenient syringe makes it simple to choose the exact dose your cat needs. Cat high blood pressure can be difficult to treat. If left undiagnosed and unmanaged, it can target vital organs in your cat’s body, including kidneys, eyes, brain and heart. SEMINTRA offers a simple and effective solution for cat owners.
What is Semintra Oral Solution for Cats 10 mg/ml, 35 ml?
Semintra Oral Solution for Cats 10 mg/ml, 35 ml is indicated for the control of systematic hypertension in cats.
Which animals/pets is Semintra Oral Solution for Cats 10 mg/ml, 35 ml for?
Cats
Semintra Oral Solution for Cats 10 mg/ml, 35 ml uses
The only FDA-approved medication to help control feline hypertension. Convenient liquid formulation, preferred by pet owners. Once daily maintenance dose after the first two weeks. Flexible dosing that can be administered in the month or on top of food. Proven safe and effective for long term use.
What does Semintra Oral Solution for Cats 10 mg/ml, 35 ml do?
The active ingredient in SEMINTRA® (telmisartan oral solution), telmisartan, belongs to a class of drugs called angiotensin receptor blockers (ARBs).1 Telmisartan helps to lower blood pressure by selectively blocking the peptide hormone the body uses to constrict blood vessels.7 This allows the blood vessels to dilate, and improves blood flow.
Semintra Oral Solution for Cats 10 mg/ml, 35 ml side effects
SEMINTRA® (telmisartan oral solution) has not been evaluated in cats with systolic blood pressure >200 mm Hg. SEMINTRA can cause mild anemia or nonregenerative anemia. Cats should be monitored for anemia when initiating treatment with SEMINTRA. SEMINTRA may cause inappetence and weight loss in some cats. Cats should be monitored for weight loss when initiating treatment with SEMINTRA. Use with caution in cats with a history of vomiting, inappetence or weight loss. The safe use of SEMINTRA in cats with hepatic disease has not been evaluated. SEMINTRA is metabolized by the liver. The safe use of SEMINTRA has not been evaluated in cats less than 9 months of age. The safe use of SEMINTRA has not been evaluated in cats that are pregnant, lactating, or intended for breeding. See Human Warnings. The safe use with other anti-hypertensive medications has not been evaluated.
Semintra Oral Solution for Cats 10 mg/ml, 35 ml ingredients
Telmisartan
Semintra Oral Solution for Cats 10 mg/ml, 35 ml overdose: What to do?
Contact your nearest emergency animal hospital.
What to know before using Semintra Oral Solution for Cats 10 mg/ml, 35 ml
IMPORTANT SAFETY INFORMATION: SEMINTRA is for use in cats only. SEMINTRA is not for human use. Keep out of reach of children. If SEMINTRA is accidentally ingested, contact a physician. Pregnant women should avoid contact with SEMINTRA because other similar drugs have been found to harm the unborn baby during pregnancy. The most common side effects reported in field studies include vomiting, diarrhea, lethargy, dehydration, poor appetite, and weight loss. If side effects should occur, pet owners should contact their veterinarian. The safe use of SEMINTRA has not been evaluated in cats less than 9 months of age or cats that are pregnant, lactating, or intended for breeding.
How is Semintra Oral Solution for Cats 10 mg/ml, 35 ml sold?
10 mg/ml, 35 ml bottle
Manufacturer
Boehringer Ingelheim
Overview

The initial dose of SEMINTRA® (telmisartan oral solution) is 1.5 mg/kg (0.68 mg/lb) orally twice daily for 14 days, followed by 2 mg/kg (0.91 mg/lb) orally once daily. The dose may be reduced by 0.5 mg/kg (0.23 mg/lb) increments to a minimum of 0.5 mg/kg (0.23 mg/lb) orally once daily to manage SEMINTRA-induced hypotension. 


Main Ingredients
Telmisartan